Welcome to Abbott’s Challenge Series! We’re excited to present three innovative challenges designed to inspire groundbreaking solutions in healthcare. Stay tuned as we unveil each challenge, with the first launching on 7 October 2024.
Open Innovation: Collaborate with Abbott to Solve Healthcare Challenges
Are you prepared to push the boundaries of healthcare innovation? This is your opportunity to collaborate with Abbott to address critical challenges in healthcare through the Start-ups Meet Pharma programme. Over the course of 2024-2025, three different challenges will be launched, offering a unique platform for start-ups to collaborate with a global leader in healthcare innovation.
Start-ups Meet Pharma is a challenge-based matchmaking programme that bridges the gap between life science corporations and innovative health start-ups. The programme is the unique gateway to present your solution and explore potential partnerships, co-development prospects, and strategic alliances that can propel your startup to new heights.
Over the course of three months, a series of meetings and workshops with global pharma executives will be co-designed, tailored to the potential collaboration opportunities that each challenge brings. The programme is tailored to maximise value for both the corporations and start-ups involved, opening doors to co-development and growth.
Applications for the first challenge are now open.
Welcome to Abbott’s Challenge Series! We’re excited to present three innovative challenges designed to inspire groundbreaking solutions in healthcare. Stay tuned as we unveil each challenge, with the first launching on 7 October 2024.
EIT Health, in partnership with Abbott has launched the first in a series of challenges and is actively seeking a solution to enhance the development of nutritional products by addressing the challenge of ingredient stability during processing. The objective is to predict these stability challenges early in the development process to avoid time-consuming and resource-heavy testing.
We are looking for solutions that can:
At present, the stability of ingredients is determined through small-scale formulation and analytical testing, which is followed by shelf-life assessments. However, this approach is costly and time-consuming, especially when evaluating multiple ingredients. Abbott is looking for a solution that can streamline this process by predicting ingredient stability based on published literature. Ideally, this solution would be an app or database of food/nutritional ingredients with search features tied to public literature databases that would be able to make data-driven recommendation on ingredient stability under various physico-chemical conditions. Such a system would help prioritise ingredients or identify potential instability early, enabling faster and more efficient product development.
This database/ programme may utilise AI-technology to scan existing published literature databases, identify studies tied to the specified ingredients as it relates to stability in various physico-chemical conditions or in presence of various micro/ macronutrients. Product users should be able to input specific processing parameters (like pH, temperature, and time) and receive predictions on how well an ingredient will perform under those conditions. The system should also generate a “stability score” and allow for multiple users to access and save search results. Ideally, this tool would be user-friendly, web-based, and capable of producing detailed, exportable reports. The ultimate goal is to have a fully functional database by Q4 2025.
For more detailed information on the challenge, please read the document here.
To apply as a start-up or SME, it must:
Webinars are a great way to find out if the programme is a right fit for you. See our webinar recording to receive firsthand information from the programme manager.
See webinar recording
Applications for the challenge are now open. The deadline for applications is 30 December 2024 15:59 CET.
Apply nowBy joining our mailing list you will: